There were 1,680 press releases posted in the last 24 hours and 429,235 in the last 365 days.

Tauriga Sciences Inc. to Commence Initial Production Run of Blood Orange Flavored Version of Tauri-Gum

New York, NY, May 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it will commence an initial production run of blood orange flavored version Tauri-Gum™, during this current operating quarter (1st fiscal Quarter of 2020 or the Period: April 1, 2019 – June 30, 2019). After recent consultations with its Manufacturer, the Company is ready to proceed with the first production run of this new flavor – all previous production of Tauri-Gum™ has been exclusively completed in MINT flavor.  The Company will incorporate two unique GS1 barcodes into the final package designs, for both the blister pack and retail display box.  The initial production run will be comprised of 8,750 blister packs or 875 retail display boxes.

Retail Box Image of Blood Orange Tauri-Gum™

Similar to the existing MINT flavor product, the blood orange version of Tauri-Gum™ will be certified as Kosher and classified as Vegan.  The Company expects that its blood orange product version will be available on its E-Commerce site ( – priced at $17.99 per blister pack!


Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases.  This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™.  The product is currently available in MINT flavor, with blood orange and pomegranate flavors confirmed as Coming Soon! See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into.  Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at

In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-Gum™ commercialization strategy.  This site can be accessed by visiting the following URL address:

Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.


Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY  10022
Chief Executive Officer
Mr. Seth M. Shaw
cell # (917) 796 9926